SUBSCRIBERS
Plant-based vaccine makers take on big boys
Their production method may turn out to be faster, cheaper
Add BT as a preferred sourcePublished Sun, Oct 5, 2014 · 09:50 PM
New York
TWO tiny companies are preparing to challenge some of the largest drug makers in the battle for dominance in the US$3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants.
The use of plants to produce life-saving pharmaceuticals captured global attention when it was revealed that the Ebola drug ZMapp is produced in the leaves of tobacco plants.
Share with us your feedback on BT's products and services
